Szeged, Hungary

Tamás Bálint Csont

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Pharmahungary 2000 Kft., Targetex Kft.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamás Bálint Csont. Retrieved from https://idiyas.com/inventor/tamas-balint-csont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tamás Bálint Csont: A Pioneer in Pharmaceutical Innovations

Introduction

Tamás Bálint Csont, a notable inventor based in Szeged, Hungary, has made significant contributions to the field of pharmaceuticals. With a strong focus on matrix metalloproteinases, his work has opened new avenues for medical treatments and innovations.

Latest Patents

Tamás holds one patent that focuses on "Inhibitors of matrix metalloproteinases - Compounds of general formula (I), salts or solvates thereof and pharmaceutical compositions containing same." This innovation targets a crucial area in pharmaceutical development, contributing to the advancement of therapies that can combat various diseases.

Career Highlights

Throughout his career, Tamás has worked with notable companies such as Pharmahungary 2000 Kft. and Targetex Kft. His experiences in these organizations have allowed him to refine his expertise in pharmaceutical research and development, leading to the creation of impactful innovations in the industry.

Collaborations

Tamás has collaborated with esteemed professionals in his field, including Péter Ferdinandy and Csaba Csonka. This teamwork has fostered a creative environment for the exploration of new ideas and has enhanced the overall impact of their collective research.

Conclusion

Tamás Bálint Csont exemplifies the spirit of innovation in the pharmaceutical industry. His patented work on matrix metalloproteinase inhibitors reflects his dedication to advancing medical science, and his collaborations highlight the importance of teamwork in achieving groundbreaking results. As he continues to navigate the world of inventions, Tamás remains a key figure in the realm of pharmaceutical innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…